SIEN-NET
Live / Registered — Registered (as of 19 Jan 2021)
What this means for you
Registered since 19 Jan 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79274546
- Registration number
- 6248001
- Mark type
- Stylized text
- Filed
- 08 Nov 2019
- Published for opposition
- 03 Nov 2020
- Registered
- 19 Jan 2021
- Attorney of record
- Charles G. Zug
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment and/or diagnosis of cancer and infectious diseases; biotechnologically-formed enzyme preparations for medical purposes; medicinal preparations for the treatment of cancer and infectious diseases; monoclonal antibodies for therapeutic purposes; products containing antibodies for use in medicine, namely, diagnostic kits consisting primarily of monoclonal antibodies used in the capture of specific biological markers for use in disease testing; proteins for binding antibodies for medical use; proteins for detecting antibodies for medical use; reagents for medical use, namely, for use in the development of monoclonal antibodies; diagnostic biomarker reagents for medical purposes; tagged antibodies for medical use; vaccines; vaccines against cancer, viral, and bacterial infection; vaccines for human use; diagnostic preparations and reagents for medical purposes; vaccine adjuvants; diagnostic preparations, reagents, and substances for medical purposes; diagnostic products and testing materials for medical purposes, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in capturing and purifying specific biological markers for use in disease testing; reagents for use in diagnostic tests for medical purposes; medical diagnostic reagents for capturing and purifying specific biological markers that can be utilised in therapeutics or diagnostics; cells for growing recombinant human protein for medical purposes; recombinant DNA technology proteins for medical use; biological reagents for use in molecular biology, namely, reagents for medical use for capturing and purifying specific biological markers that contain nucleic acid; antibodies that are specifically able to bind and capture specific biological markers for medical purposes; antibody fragments that are specifically able to bind and capture specific biological markers for medical purposes; antibody conjugates that are specifically able to bind and capture specific biological markers for medical purposes; pharmaceutical preparations for the treatment, reconstruction and repair of antibodies; immunological antibodies for medical use; monoclonal antibodies for medical diagnostic use; monoclonal antibodies for medical use
Owner
Prosecution history
- 19 Jan 2026 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 16 May 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 23 Apr 2021 — FINAL DISPOSITION NOTICE SENT TO IB
- 23 Apr 2021 — FINAL DISPOSITION PROCESSED
- 19 Apr 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 29 Jan 2021 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 19 Jan 2021 — REGISTERED-PRINCIPAL REGISTER
- 03 Nov 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Nov 2020 — PUBLISHED FOR OPPOSITION
- 02 Nov 2020 — NOTIFICATION PROCESSED BY IB
- 14 Oct 2020 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 14 Oct 2020 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 14 Oct 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Sept 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Sept 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED